Supplementary Methods Table 1 from Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma
MacLean S. Hall,John E. Mullinax,Cheryl A. Cox,Amy M. Hall,Matthew S. Beatty,Jamie Blauvelt,Patrick Innamarato,Luz Nagle,Holly Branthoover,Doris Wiener,Benjamin Schachner,Alberto J. Martinez,Allison D. Richards,Carolyn J. Rich,Colón,Michael J. Schell,Jamie K. Teer,Nikhil I. Khushalani,Jeffrey S. Weber,James J. Mulé,Vernon K. Sondak,Shari Pilon-Thomas,Amod A. Sarnaik
